Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
|
CN |
|
B
|
Baudroie Inc
TSE:4413
|
JP |
|
Italmobiliare SpA
MIL:ITM
|
IT |
|
Jammu and Kashmir Bank Ltd
BSE:532209
|
IN |
|
S
|
SSI Group Inc
XPHS:SSI
|
PH |
|
K
|
Kiler Holding AS
IST:KLRHO.E
|
TR |
|
Consus Real Estate AG
XETRA:CC1
|
DE |
|
M
|
MoneyGram International Inc
F:9M1N
|
US |
|
V
|
Vsolar Group Bhd
KLSE:VSOLAR
|
MY |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Zhejiang Shengda Bio-Pharm Co Ltd's stock price target?
Not Available
Zhejiang Shengda Bio-Pharm Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Zhejiang Shengda Bio-Pharm Co Ltd's Revenue forecast?
Projected CAGR
-6%
For the last 9 years the compound annual growth rate for Zhejiang Shengda Bio-Pharm Co Ltd's revenue is 5%. The projected CAGR for the next 7 years is -6%.
What is Zhejiang Shengda Bio-Pharm Co Ltd's Net Income forecast?
Projected CAGR
14%
For the last 9 years the compound annual growth rate for Zhejiang Shengda Bio-Pharm Co Ltd's net income is -11%. The projected CAGR for the next 7 years is 14%.
